Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of CPP-ACP on Bleaching Related Sensitivity
NCT04112706Completed
- Sponsor
- University of New England
- Start
- Jul 2006
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of casein phosphopeptide-amorphous calcium phosphate in dentin hypersensitivity (DH) (2 arms), sponsored by University of New England. Primary endpoints: Subjective Sensitivity (VAS) at 28 days and Objective Sensitivity (Air Blast) at 28 days. Started Jul 2006; status: completed.
02
Drugs
casein phosphopeptide-amorphous calcium phosphate
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT04112706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04112706.